针对癌症治疗的DNA修复:来自PARP抑制剂试验的教训
Dhanya K Nambiar1, Deepali Mishra2, Rana P Singh2,3
1Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Oncology research
|July 7, 2023
概括
聚-ADP-ribose) 聚合酶-1 (PARP-1) 抑制剂通过阻断DNA修复,提高辐射效率,特别是在前列腺癌中,在癌症治疗中表现有前途. 研究探讨了它们的发展和对各种瘤的临床使用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 辐射疗法 辐射疗法
背景情况:
- 电离辐射是固体瘤治疗的基石,诱导DNA损伤以消除癌细胞.
- 聚基聚合酶-1 (PARP-1) 在DNA修复中起着关键作用,有助于治疗耐药性.
- 在瘤学中,PARP-1 是一个关键的目标,特别是在前列腺癌等癌症中.
研究的目的:
- 为了提供一个简化概述的多- ((ADP-ribose) 聚合酶-1 (PARP-1) 抑制剂的发展.
- 讨论PARP抑制剂在癌症治疗中的实验室和临床应用.
- 突出PARP抑制剂在前列腺癌和其他恶性瘤中的作用.
主要方法:
- 关于PARP抑制剂的科学文献的综述.
- 对PARP抑制剂疗效的临床前和临床数据的分析.
- 探索与PARP抑制相关的作用和抵抗机制.
主要成果:
- 抑制PARP-1对缺乏同源重组修复 (HR) 的癌细胞是致命的.
- PARP 抑制剂已经在各种癌症类型中表现出有效性.
- PARP 抑制剂的开发已经从实验室研究向临床应用发展.
结论:
- 在瘤学中,PARP-1 是一个经过验证的治疗点.
- PARP 抑制剂代表了癌症治疗策略的重大进步.
- 了解这些原则和挑战对于优化PARP抑制剂的临床疗效至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Base Excision Repair
22.6K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
22.6K
Long-patch Base Excision Repair
7.1K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.1K
Nucleotide Excision Repair
3.6K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.6K
Base-pairing and DNA Repair
64.8K
64.8K
Overview of DNA Repair
31.1K
In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Chemically...
31.1K


